{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:09:38Z","timestamp":1791295778226,"version":"4.1.0"},"reference-count":50,"publisher":"American Association for Cancer Research (AACR)","issue":"7","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2008,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>To date, no prospective studies have explored the relationship between the use of aspirin, other nonsteroidal anti-inflammatory medications (NSAID), and acetaminophen and endometrial adenocarcinoma. Of the 82,971 women enrolled in a prospective cohort study, 747 developed medical record\u2013confirmed invasive endometrial cancer over a 24-year period. Use of aspirin was ascertained from 1980 to 2004, and for other NSAIDs and acetaminophen, from 1990 to 2004. Cox regression models calculated multivariate relative risks (MV RR), controlling for body mass index (BMI), postmenopausal hormone (PMH) use, and other endometrial cancer risk factors. Currency, duration, and quantity of aspirin were not associated with endometrial cancer risk overall [current use: MV RR, 1.03; 95% confidence interval (CI) 0.83\u20131.27; &amp;gt;10 years of use: MV RR, 1.01; 95% CI, 0.78\u20131.30; and cumulative average &amp;gt;7 tablets per week: (MV RR, 1.10; 95% CI, 0.84\u20131.44)]. However, stratified analyses showed that a lower risk of endometrial cancer among obese (BMI, \u226530 kg\/m2) women was seen with current aspirin use (MV RR, 0.66; 95% CI, 0.46\u20130.95). The greatest risk reduction for current aspirin users was seen in postmenopausal obese women who had never used PMH (MV RR, 0.43; 95% CI, 0.26\u20130.73). The use of other NSAIDs or acetaminophen was not associated with endometrial cancer. Our data suggest that use of aspirin or other NSAIDs does not play an important role in endometrial cancer risk overall. However, risk was significantly lower for current aspirin users who were obese or who were postmenopausal and had never used PMHs; these subgroup findings require further confirmation. [Cancer Res 2008;68(7):2507\u201313]<\/jats:p>","DOI":"10.1158\/0008-5472.can-07-6257","type":"journal-article","created":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T19:44:16Z","timestamp":1207079056000},"page":"2507-2513","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Aspirin, NSAID, and Acetaminophen Use and the Risk of Endometrial Cancer"],"prefix":"10.1158","volume":"68","author":[{"given":"Akila N.","family":"Viswanathan","sequence":"first","affiliation":[{"name":"1Department of Radiation Oncology, Brigham and Women's Hospital\/Dana-Farber Cancer Institute and Harvard Medical School;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Feskanich","sequence":"additional","affiliation":[{"name":"2Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva S.","family":"Schernhammer","sequence":"additional","affiliation":[{"name":"2Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School; and"},{"name":"3Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan E.","family":"Hankinson","sequence":"additional","affiliation":[{"name":"2Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School; and"},{"name":"3Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2008,4,1]]},"reference":[{"key":"2022061700304452500_B1","doi-asserted-by":"crossref","unstructured":"Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet\u20082001; 357: 539\u201345.","DOI":"10.1016\/S0140-6736(00)04046-0"},{"key":"2022061700304452500_B2","doi-asserted-by":"crossref","unstructured":"Coussens LM, Werb Z. Inflammatory cells and cancer: think different! J Exp Med\u20082001; 193: F23\u20136.","DOI":"10.1084\/jem.193.6.F23"},{"key":"2022061700304452500_B3","doi-asserted-by":"crossref","unstructured":"Coussens LM, Werb Z. Inflammation and cancer. Nature\u20082002; 420: 860\u20137.","DOI":"10.1038\/nature01322"},{"key":"2022061700304452500_B4","doi-asserted-by":"crossref","unstructured":"Finn CA. Implantation, menstruation and inflammation. Biol Rev Camb Philos Soc\u20081986; 61: 313\u201328.","DOI":"10.1111\/j.1469-185X.1986.tb00657.x"},{"key":"2022061700304452500_B5","doi-asserted-by":"crossref","unstructured":"Modugno F, Ness RB, Chen C, Weiss NS. Inflammation and endometrial cancer: a hypothesis. Cancer Epidemiol Biomarkers Prev\u20082005; 14: 2840\u20137.","DOI":"10.1158\/1055-9965.EPI-05-0493"},{"key":"2022061700304452500_B6","doi-asserted-by":"crossref","unstructured":"Moysich KB, Baker JA, Rodabaugh KJ, Villella JA. Regular analgesic use and risk of endometrial cancer. Cancer Epidemiol Biomarkers Prev\u20082005; 14: 2923\u20138.","DOI":"10.1158\/1055-9965.EPI-05-0457"},{"key":"2022061700304452500_B7","doi-asserted-by":"crossref","unstructured":"Colditz GA, Manson JE, Hankinson SE. The Nurses' Health Study: 20-year contribution to the understanding of health among women. J Womens Health\u20081997; 6: 49\u201362.","DOI":"10.1089\/jwh.1997.6.49"},{"key":"2022061700304452500_B8","doi-asserted-by":"crossref","unstructured":"Giovannucci E, Egan KM, Hunter DJ, et al. Aspirin and the risk of colorectal cancer in women. N Engl J Med\u20081995; 333: 609\u201314.","DOI":"10.1056\/NEJM199509073331001"},{"key":"2022061700304452500_B9","doi-asserted-by":"crossref","unstructured":"Rimm EB, Stampfer MJ, Colditz GA, Chute CG, Litin LB, Willett WC. Validity of self-reported waist and hip circumferences in men and women. Epidemiology\u20081990; 1: 466\u201373.","DOI":"10.1097\/00001648-199011000-00009"},{"key":"2022061700304452500_B10","doi-asserted-by":"crossref","unstructured":"Colditz GA, Stampfer MJ, Willett WC, et al. Reproducibility and validity of self-reported menopausal status in a prospective cohort study. Am J Epidemiol\u20081987; 126: 319\u201325.","DOI":"10.1093\/aje\/126.2.319"},{"key":"2022061700304452500_B11","doi-asserted-by":"crossref","unstructured":"Hagenfeldt K. The role of prostaglandins and allied substances in uterine haemostasis. Contraception\u20081987; 36: 23\u201335.","DOI":"10.1016\/0010-7824(87)90059-X"},{"key":"2022061700304452500_B12","doi-asserted-by":"crossref","unstructured":"Landen CN, Jr., Mathur SP, Richardson MS, Creasman WT. Expression of cyclooxygenase-2 in cervical, endometrial, and ovarian malignancies. Am J Obstet Gynecol\u20082003; 188: 1174\u20136.","DOI":"10.1067\/mob.2003.284"},{"key":"2022061700304452500_B13","doi-asserted-by":"crossref","unstructured":"Jabbour HN, Milne SA, Williams AR, Anderson RA, Boddy SC. Expression of COX-2 and PGE synthase and synthesis of PGE(2)in endometrial adenocarcinoma: a possible autocrine\/paracrine regulation of neoplastic cell function via EP2\/EP4 receptors. Br J Cancer\u20082001; 85: 1023\u201331.","DOI":"10.1054\/bjoc.2001.2033"},{"key":"2022061700304452500_B14","doi-asserted-by":"crossref","unstructured":"Tamura M, Sebastian S, Yang S, et al. Up-regulation of cyclooxygenase-2 expression and prostaglandin synthesis in endometrial stromal cells by malignant endometrial epithelial cells. A paracrine effect mediated by prostaglandin E2 and nuclear factor-\u03baB. J Biol Chem\u20082002; 277: 26208\u201316.","DOI":"10.1074\/jbc.M201347200"},{"key":"2022061700304452500_B15","doi-asserted-by":"crossref","unstructured":"Uotila PJ, Erkkola RU, Klemi PJ. The expression of cyclooxygenase-1 and -2 in proliferative endometrium and endometrial adenocarcinoma. Ann Med\u20082002; 34: 428\u201333.","DOI":"10.1080\/078538902321012379"},{"key":"2022061700304452500_B16","doi-asserted-by":"crossref","unstructured":"Ferrandina G, Legge F, Ranelletti FO, et al. Cyclooxygenase-2 expression in endometrial carcinoma: correlation with clinicopathologic parameters and clinical outcome. Cancer\u20082002; 95: 801\u20137.","DOI":"10.1002\/cncr.10736"},{"key":"2022061700304452500_B17","doi-asserted-by":"crossref","unstructured":"Zhao Y, Agarwal VR, Mendelson CR, Simpson ER. Estrogen biosynthesis proximal to a breast tumor is stimulated by PGE2 via cyclic AMP, leading to activation of promoter II of the CYP19 (aromatase) gene. Endocrinology\u20081996; 137: 5739\u201342.","DOI":"10.1210\/endo.137.12.8940410"},{"key":"2022061700304452500_B18","doi-asserted-by":"crossref","unstructured":"Brueggemeier RW, Richards JA, Petrel TA. Aromatase and cyclooxygenases: enzymes in breast cancer. J Steroid Biochem Mol Biol\u20082003; 86: 501\u20137.","DOI":"10.1016\/S0960-0760(03)00380-7"},{"key":"2022061700304452500_B19","doi-asserted-by":"crossref","unstructured":"Fowler JM, Ramirez N, Cohn DE, et al. Correlation of cyclooxygenase-2 (COX-2) and aromatase expression in human endometrial cancer: tissue microarray analysis. Am J Obstet Gynecol\u20082005; 192: 1262\u201371; discussion 71\u20133.","DOI":"10.1016\/j.ajog.2005.01.009"},{"key":"2022061700304452500_B20","doi-asserted-by":"crossref","unstructured":"Arango HA, Icely S, Roberts WS, Cavanagh D, Becker JL. Aspirin effects on endometrial cancer cell growth. Obstet Gynecol\u20082001; 97: 423\u20137.","DOI":"10.1097\/00006250-200103000-00019"},{"key":"2022061700304452500_B21","doi-asserted-by":"crossref","unstructured":"Gao J, Niwa K, Sun W, et al. Non-steroidal anti-inflammatory drugs inhibit cellular proliferation and upregulate cyclooxygenase-2 protein expression in endometrial cancer cells. Cancer Sci\u20082004; 95: 901\u20137.","DOI":"10.1111\/j.1349-7006.2004.tb02200.x"},{"key":"2022061700304452500_B22","doi-asserted-by":"crossref","unstructured":"Wood NJ, Quinton NA, Burdall S, Sheridan E, Duffy SR. Exploring the potential chemopreventative effect of aspirin and rofecoxib on hereditary nonpolyposis colorectal cancer-like endometrial cancer cells in vitro through mechanisms involving apoptosis, the cell cycle, and mismatch repair gene expression. Int J Gynecol Cancer\u20082007; 17: 447\u201354.","DOI":"10.1111\/j.1525-1438.2007.00867.x"},{"key":"2022061700304452500_B23","unstructured":"Kaaks R, Lukanova A, Kurzer MS. Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review. Cancer Epidemiol Biomarkers Prev\u20082002; 11: 1531\u201343."},{"key":"2022061700304452500_B24","doi-asserted-by":"crossref","unstructured":"Weiderpass E, Baron JA, Adami HO, et al. Low-potency oestrogen and risk of endometrial cancer: a case-control study. Lancet\u20081999; 353: 1824\u20138.","DOI":"10.1016\/S0140-6736(98)10233-7"},{"key":"2022061700304452500_B25","doi-asserted-by":"crossref","unstructured":"Weiderpass E, Adami HO, Baron JA, et al. Risk of endometrial cancer following estrogen replacement with and without progestins. J Natl Cancer Inst\u20081999; 91: 1131\u20137.","DOI":"10.1093\/jnci\/91.13.1131"},{"key":"2022061700304452500_B26","doi-asserted-by":"crossref","unstructured":"Shu XO, Brinton LA, Zheng W, Gao YT, Fan J, Fraumeni JF, Jr. A population-based case-control study of endometrial cancer in Shanghai, China. Int J Cancer\u20081991; 49: 38\u201343.","DOI":"10.1002\/ijc.2910490108"},{"key":"2022061700304452500_B27","doi-asserted-by":"crossref","unstructured":"Kelsey JL, LiVolsi VA, Holford TR, et al. A case-control study of cancer of the endometrium. Am J Epidemiol\u20081982; 116: 333\u201342.","DOI":"10.1093\/oxfordjournals.aje.a113417"},{"key":"2022061700304452500_B28","doi-asserted-by":"crossref","unstructured":"Koumantaki Y, Tzonou A, Koumantakis E, Kaklamani E, Aravantinos D, Trichopoulos D. A case-control study of cancer of endometrium in Athens. Int J Cancer\u20081989; 43: 795\u20139.","DOI":"10.1002\/ijc.2910430509"},{"key":"2022061700304452500_B29","doi-asserted-by":"crossref","unstructured":"Terry P, Baron JA, Weiderpass E, Yuen J, Lichtenstein P, Nyren O. Lifestyle and endometrial cancer risk: a cohort study from the Swedish Twin Registry. Int J Cancer\u20081999; 82: 38\u201342.","DOI":"10.1002\/(SICI)1097-0215(19990702)82:1<38::AID-IJC8>3.0.CO;2-Q"},{"key":"2022061700304452500_B30","doi-asserted-by":"crossref","unstructured":"Parslov M, Lidegaard O, Klintorp S, et al. Risk factors among young women with endometrial cancer: a Danish case-control study. Am J Obstet Gynecol\u20082000; 182: 23\u20139.","DOI":"10.1016\/S0002-9378(00)70486-8"},{"key":"2022061700304452500_B31","doi-asserted-by":"crossref","unstructured":"Viswanathan AN, Feskanich D, De Vivo I, et al. Smoking and the risk of endometrial cancer: results from the Nurses' Health Study. Int J Cancer\u20082005; 114: 996\u20131001.","DOI":"10.1002\/ijc.20821"},{"key":"2022061700304452500_B32","doi-asserted-by":"crossref","unstructured":"Levi F, La Vecchia C, Negri E, Parazzini F, Franceschi S. Body mass at different ages and subsequent endometrial cancer risk. Int J Cancer\u20081992; 50: 567\u201371.","DOI":"10.1002\/ijc.2910500413"},{"key":"2022061700304452500_B33","doi-asserted-by":"crossref","unstructured":"Jain MG, Rohan TE, Howe GR. Hormone replacement therapy and endometrial cancer in Ontario, Canada. J Clin Epidemiol\u20082000; 53: 385\u201391.","DOI":"10.1016\/S0895-4356(99)00192-4"},{"key":"2022061700304452500_B34","doi-asserted-by":"crossref","unstructured":"Kelly RW, King AE, Critchley HO. Inflammatory mediators and endometrial function-focus on the perivascular cell. J Reprod Immunol\u20082002; 57: 81\u201393.","DOI":"10.1016\/S0165-0378(02)00008-6"},{"key":"2022061700304452500_B35","doi-asserted-by":"crossref","unstructured":"d'Arcangues C, Piaggio G, Brache V, et al. Effectiveness and acceptability of vitamin E and low-dose aspirin, alone or in combination, on Norplant-induced prolonged bleeding. Contraception\u20082004; 70: 451\u201362.","DOI":"10.1016\/j.contraception.2004.05.012"},{"key":"2022061700304452500_B36","doi-asserted-by":"crossref","unstructured":"Gann PH, Manson JE, Glynn RJ, Buring JE, Hennekens CH. Low-dose aspirin and incidence of colorectal tumors in a randomized trial. J Natl Cancer Inst\u20081993; 85: 1220\u20134.","DOI":"10.1093\/jnci\/85.15.1220"},{"key":"2022061700304452500_B37","unstructured":"Kune GA, Kune S, Watson LF. Colorectal cancer risk, chronic illnesses, operations, and medications: case control results from the Melbourne Colorectal Cancer Study. Cancer Res\u20081988; 48: 4399\u2013404."},{"key":"2022061700304452500_B38","doi-asserted-by":"crossref","unstructured":"Garcia-Rodriguez LA, Huerta-Alvarez C. Reduced risk of colorectal cancer among long-term users of aspirin and nonaspirin nonsteroidal antiinflammatory drugs. Epidemiology\u20082001; 12: 88\u201393.","DOI":"10.1097\/00001648-200101000-00015"},{"key":"2022061700304452500_B39","doi-asserted-by":"crossref","unstructured":"Baron JA. Epidemiology of non-steroidal anti-inflammatory drugs and cancer. Prog Exp Tumor Res\u20082003; 37: 1\u201324.","DOI":"10.1159\/000071364"},{"key":"2022061700304452500_B40","doi-asserted-by":"crossref","unstructured":"Dube C, Rostom A, Lewin G, et al. The use of aspirin for primary prevention of colorectal cancer: a systematic review prepared for the U.S. Preventive Services Task Force. Ann Intern Med\u20082007; 146: 365\u201375.","DOI":"10.7326\/0003-4819-146-5-200703060-00009"},{"key":"2022061700304452500_B41","doi-asserted-by":"crossref","unstructured":"Baron JA, Cole BF, Sandler RS, et al. A randomized trial of aspirin to prevent colorectal adenomas. N Engl J Med\u20082003; 348: 891\u20139.","DOI":"10.1056\/NEJMoa021735"},{"key":"2022061700304452500_B42","unstructured":"Harris RE, Chlebowski RT, Jackson RD, et al. Breast cancer and nonsteroidal anti-inflammatory drugs: prospective results from the Women's Health Initiative. Cancer Res\u20082003; 63: 6096\u2013101."},{"key":"2022061700304452500_B43","doi-asserted-by":"crossref","unstructured":"Garcia Rodriguez LA, Gonzalez-Perez A. Risk of breast cancer among users of aspirin and other anti-inflammatory drugs. Br J Cancer\u20082004; 91: 525\u20139.","DOI":"10.1038\/sj.bjc.6602003"},{"key":"2022061700304452500_B44","unstructured":"Johnson TW, Anderson KE, Lazovich D, Folsom AR. Association of aspirin and nonsteroidal anti-inflammatory drug use with breast cancer. Cancer Epidemiol Biomarkers Prev\u20082002; 11: 1586\u201391."},{"key":"2022061700304452500_B45","doi-asserted-by":"crossref","unstructured":"Schernhammer ES, Kang JH, Chan AT, et al. A prospective study of aspirin use and the risk of pancreatic cancer in women. J Natl Cancer Inst\u20082004; 96: 22\u20138.","DOI":"10.1093\/jnci\/djh001"},{"key":"2022061700304452500_B46","doi-asserted-by":"crossref","unstructured":"Jacobs EJ, Connell CJ, Rodriguez C, Patel AV, Calle EE, Thun MJ. Aspirin use and pancreatic cancer mortality in a large United States cohort. J Natl Cancer Inst\u20082004; 96: 524\u20138.","DOI":"10.1093\/jnci\/djh084"},{"key":"2022061700304452500_B47","doi-asserted-by":"crossref","unstructured":"Cook NR, Lee IM, Gaziano JM, et al. Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial. JAMA\u20082005; 294: 47\u201355.","DOI":"10.1001\/jama.294.1.47"},{"key":"2022061700304452500_B48","doi-asserted-by":"crossref","unstructured":"Botting R, Ayoub SS. COX-3 and the mechanism of action of paracetamol\/acetaminophen. Prostaglandins Leukot Essent Fatty Acids\u20082005; 72: 85\u20137.","DOI":"10.1016\/j.plefa.2004.10.005"},{"key":"2022061700304452500_B49","unstructured":"National Toxicology Program. Toxicology and carcinogenesis studies of acetaminophen (CAS No. 103\u201390\u20132) in G344\/N rats and B6C3F1 mice (feed studies). Research Triangle Park (NC): U.S. Department of Health and Human Services, Public Health Service, National Instutites of Health; 1993."},{"key":"2022061700304452500_B50","doi-asserted-by":"crossref","unstructured":"Cramer DW, Liberman RF, Hornstein MD, et al. Basal hormone levels in women who use acetaminophen for menstrual pain. Fertil Steril\u20081998; 70: 371\u20133.","DOI":"10.1016\/S0015-0282(98)00153-8"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/68\/7\/2507\/2594014\/2507.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/68\/7\/2507\/2594014\/2507.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T05:45:06Z","timestamp":1655444706000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/68\/7\/2507\/540881\/Aspirin-NSAID-and-Acetaminophen-Use-and-the-Risk"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4,1]]},"references-count":50,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2008,4,1]]},"published-print":{"date-parts":[[2008,4,1]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-07-6257","relation":{},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,4,1]]}}}